Castle Biosciences Inc (CSTL)
20.08
+0.47
(+2.40%)
USD |
NASDAQ |
Apr 23, 16:00
20.08
0.00 (0.00%)
After-Hours: 16:00
Castle Biosciences Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.1348 |
| June 30, 2020 | 0.157 |
| March 31, 2020 | 0.2882 |
| December 31, 2019 | 0.2952 |
| September 30, 2019 | 0.3025 |
| June 30, 2019 | -8.102 |
| March 31, 2019 | 11.81 |
| December 31, 2018 | -2.433 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-8.102
Minimum
Jun 2019
0.3025
Maximum
Sep 2019
-0.3644
Average
--
Median
Dec 2020
Debt to Equity Ratio Benchmarks
| Exact Sciences Corp | 0.7517 |
| Illumina Inc | 0.2592 |
| Mettler-Toledo International Inc | -13.88 |
| Waters Corp | 2.048 |
| Natera Inc | 0.4748 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 453.34M |
| Total Liabilities (Quarterly) | 62.07M |
| Shareholders Equity (Quarterly) | 391.27M |
| Current Ratio | 6.202 |